Corline Biomedical AB (CLBIO.ST) - Stock Prices, Stock Peers & Analysis

Home
CLBIO.ST

Company Name	Corline Biomedical AB
Symbol	CLBIO.ST
Currency	SEK
Price	13.8
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	296,573,040
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	8.92 - 19.85
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Henrik Nittmar Ph.D.
Website	https://www.corline.se

An error occurred while fetching data.

About Corline Biomedical AB

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment